Boyuan Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Boyuan Ma has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chengjiang Liu
Department of Painology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Rusen Zhu
Department of Spine Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University
1 shared publication - Shun-Li Kan
Department of Spine Surgery, Tianjin Union Medical Center, Tianjin, China
1 shared publication - Wei Hu
Department of Spine Surgery, Tianjin Union Medical Center Tianjin, Tianjin, China
1 shared publication - Xinyan Zhao
Department of Spine Surgery, Tianjin Union Medical Center Tianjin, Tianjin, China
1 shared publication - Xuanhao Fu
Department of Spine Surgery, Tianjin Union Medical Center Tianjin, Tianjin, China
1 shared publication
Latest Publications
- Open Access
- 18 November 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (46) , e31930
Mitochondrial regulatory mechanisms in spinal cord injury: A narrative review
Spinal cord injury is a severe central nervous system injury that results in the permanent loss of motor, sensory, and autonomic functions below the level of injury with limited recovery. The pathological process of spinal cord injury includes primary and secondary injuries, characterized by a progressive cascade. Secondary injury impairs the ability of the mitochondria to maintain homeostasis and leads to calcium overload, excitotoxicity, and oxidative stress, further exacerbating the injury. The defective mitochondrial function observed in these pathologies accelerates neuronal cell death and inhibits regeneration. Treatment of spinal cord injury by preserving mitochondrial biological function is a promising, although still underexplored, therapeutic strategy. This review aimed to explore mitochondrial-based therapeutic advances after spinal cord injury. Specifically, it briefly describes the characteristics of spinal cord injury. It then broadly discusses the drugs used to protect the mitochondria (e.g., cyclosporine A, acetyl-L-carnitine, and alpha-tocopherol), phenomena associated with mitochondrial damage processes (e.g., mitophagy, ferroptosis, and cuproptosis), mitochondrial transplantation for nerve cell regeneration, and innovative mitochondrial combined protection therapy.
- 18 November 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (46) , e31930
Open AccessMitochondrial regulatory mechanisms in spinal cord injury: A narrative review
Spinal cord injury is a severe central nervous system injury that results in the permanent loss of motor, sensory, and autonomic functions below the level of injury with limited recovery. The pathological process of spinal cord injury includes primary and secondary injuries, characterized by a progressive cascade. Secondary injury impairs the ability of the mitochondria to maintain homeostasis and leads to calcium overload, excitotoxicity, and oxidative stress, further exacerbating the injury. The defective mitochondrial function observed in these pathologies accelerates neuronal cell death and inhibits regeneration. Treatment of spinal cord injury by preserving mitochondrial biological function is a promising, although still underexplored, therapeutic strategy. This review aimed to explore mitochondrial-based therapeutic advances after spinal cord injury. Specifically, it briefly describes the characteristics of spinal cord injury. It then broadly discusses the drugs used to protect the mitochondria (e.g., cyclosporine A, acetyl-L-carnitine, and alpha-tocopherol), phenomena associated with mitochondrial damage processes (e.g., mitophagy, ferroptosis, and cuproptosis), mitochondrial transplantation for nerve cell regeneration, and innovative mitochondrial combined protection therapy.